Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline

被引:0
作者
Wybitul, Maha [1 ,2 ]
Buchmann, Andreas [1 ]
Langer, Nicolas [3 ]
Hock, Christoph [1 ,4 ]
Treyer, Valerie [1 ,5 ]
Gietl, Anton [1 ,6 ]
机构
[1] Univ Zurich, Inst Regenerat Med, Fac Med, CH-8952 Schlieren, Switzerland
[2] Univ Zurich, Fac Philosophy, Dept Psychol, CH-8050 Zurich, Switzerland
[3] Univ Zurich, Dept Psychol, Methods Plast Res, CH-8050 Zurich, Switzerland
[4] Neurimmune, CH-8952 Schlieren, Switzerland
[5] Univ Zurich, Dept Nucl Med, CH-8091 Zurich, Switzerland
[6] Univ Hosp Geriatr Psychiat, CH-8008 Zurich, Switzerland
关键词
Amyloid beta accumulation; APOE; Aging; Cognition; Alzheimer's disease; PET-imaging; CEREBRAL-BLOOD-FLOW; APOLIPOPROTEIN-E EPSILON-4; ALZHEIMERS-DISEASE; A-BETA; TYPE-4; ALLELE; OLDER-ADULTS; ASSOCIATION; DEPOSITION; INDIVIDUALS; BIOMARKERS;
D O I
10.1016/j.neurobiolaging.2024.03.007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Amyloid beta (A beta) follows a sigmoidal time function with varying accumulation rates. We studied how the position on this function, reflected by different A beta accumulation phases, influences APOE z4's association with A beta and cognitive decline in 503 participants without dementia using A beta-PET imaging over 5.3-years. First, A beta load and accumulation were analyzed irrespective of phases using linear mixed regression. Generally, z4 carriers displayed a higher A beta load. Moreover, A beta normal (A beta-) z4 carriers demonstrated higher accumulation. Next, we categorized accumulation phases as "decrease", "stable", or "increase" based on trajectory shapes. After excluding the A beta-/decrease participants from the initial regression, the difference in accumulation attributable to genotype among A beta- individuals was no longer significant. Further analysis revealed that in increase phases, A beta accumulation was higher among noncarriers, indicating a genotype-related timeline shift. Finally, cognitive decline was analyzed across phases and was already evident in the A beta-/increase phase. Our results encourage early interventions for z4 carriers and imply that monitoring accumulating A beta- individuals might help identify those at risk for cognitive decline.
引用
收藏
页码:44 / 53
页数:10
相关论文
共 72 条
  • [51] Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale
    Navitsky, Michael
    Joshi, Abhinay D.
    Kennedy, Ian
    Klunk, William E.
    Rowe, Christopher C.
    Wong, Dean F.
    Pontecorvo, Michael J.
    Mintun, Mark A.
    Devous, Michael D., Sr.
    [J]. ALZHEIMERS & DEMENTIA, 2018, 14 (12) : 1565 - 1571
  • [52] APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review
    O'Donoghue, M. Clare
    Murphy, Susannah E.
    Zamboni, Giovanna
    Nobre, Anna C.
    Mackay, Clare E.
    [J]. CORTEX, 2018, 104 : 103 - 123
  • [53] Parhizkar S., 2022, SEM IMM
  • [54] Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts
    Resnick, Susan M.
    Bilgel, Murat
    Moghekar, Abhay
    An, Yang
    Cai, Qing
    Wang, Mei-Cheng
    Thambisetty, Madhav
    Prince, Jerry L.
    Zhou, Yun
    Soldan, Anja
    Wong, Dean F.
    O'Brien, Richard J.
    Ferrucci, Luigi
    Albert, Marilyn S.
    [J]. NEUROBIOLOGY OF AGING, 2015, 36 (08) : 2333 - 2339
  • [55] Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
    Royse, Sarah K.
    Minhas, Davneet S.
    Lopresti, Brian J.
    Murphy, Alice
    Ward, Tyler
    Koeppe, Robert A.
    Bullich, Santiago
    DeSanti, Susan
    Jagust, William J.
    Landau, Susan M.
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [56] Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
    Rullmann, Michael
    McLeod, Anke
    Grothe, Michel J.
    Sabri, Osama
    Barthel, Henryk
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (12) : 1820 - 1824
  • [57] Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
    Salvado, Gemma
    Luis Molinuevo, Jose
    Brugulat-Serrat, Anna
    Falcon, Carles
    Grau-Rivera, Oriol
    Suarez-Calvet, Marc
    Pavia, Javier
    Ninerola-Baizan, Aida
    Perissinotti, Andres
    Lomena, Francisco
    Minguillon, Carolina
    Fauria, Karine
    Zetterberg, Henrik
    Blennow, Kaj
    Domingo Gispert, Juan
    Cami, Jordi
    Cacciaglia, Raffaele
    Crous-Bou, Marta
    Deulofeu, Carme
    Dominguez, Ruth
    Gotsens, Xavi
    Gramunt, Nina
    Hernandez, Laura
    Huesa, Gema
    Huguet, Jordi
    Leon, Maria
    Marne, Paula
    Menchon, Tania
    Mila, Marta
    Operto, Gregory
    Pascual, Maria
    Polo, Albina
    Pradas, Sandra
    Sala-Vila, Aleix
    Sanchez-Benavides, Gonzalo
    Segundo, Sabrina
    Soteras, Anna
    Tenas, Laia
    Vilanova, Marc
    Vilor-Tejedor, Natalia
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (1)
  • [58] APOLIPOPROTEIN-E - HIGH-AVIDITY BINDING TO BETA-AMYLOID AND INCREASED FREQUENCY OF TYPE-4 ALLELE IN LATE-ONSET FAMILIAL ALZHEIMER-DISEASE
    STRITTMATTER, WJ
    SAUNDERS, AM
    SCHMECHEL, D
    PERICAKVANCE, M
    ENGHILD, J
    SALVESEN, GS
    ROSES, AD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) : 1977 - 1981
  • [59] Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies
    Su, Yi
    Flores, Shaney
    Wang, Guoqiao
    Hornbeck, Russ C.
    Speidel, Benjamin
    Joseph-Mathurin, Nelly
    Vlassenko, Andrei G.
    Gordon, Brian A.
    Koeppe, Robert A.
    Klunk, William E.
    Jack, Clifford R.
    Farlow, Martin R.
    Salloway, Stephen
    Snider, Barbara J.
    Berman, Sarah B.
    Roberson, Erik D.
    Brosch, Jared
    Jimenez-Velazques, Ivonne
    van Dyck, Christopher H.
    Galasko, Douglas
    Yuan, Shauna H.
    Jayadev, Suman
    Honig, Lawrence S.
    Gauthier, Serge
    Hsiung, Ging-Yuek R.
    Masellis, Mario
    Brooks, William S.
    Fulham, Michael
    Clarnette, Roger
    Masters, Colin L.
    Wallon, David
    Hannequin, Didier
    Dubois, Bruno
    Pariente, Jeremie
    Sanchez-Valle, Raquel
    Mummery, Catherine
    Ringman, John M.
    Bottlaender, Michel
    Klein, Gregory
    Milosavljevic-Ristic, Smiljana
    McDade, Eric
    Xiong, Chengjie
    Morris, John C.
    Bateman, Randall J.
    Benzinger, Tammie L. S.
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 180 - 190
  • [60] Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913